These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 2071784)

  • 1. Differences in clinical and immunologic reactivity of patients allergic to grass pollens and to multiple-pollen species. II. Efficacy of a double-blind, placebo-controlled, specific immunotherapy with standardized extracts.
    Bousquet J; Becker WM; Hejjaoui A; Chanal I; Lebel B; Dhivert H; Michel FB
    J Allergy Clin Immunol; 1991 Jul; 88(1):43-53. PubMed ID: 2071784
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical and immunologic reactivity of patients allergic to grass pollens and to multiple pollen species. I. Clinical and immunologic characteristics.
    Bousquet J; Hejjaoui A; Becker WM; Cour P; Chanal I; Lebel B; Dhivert H; Michel FB
    J Allergy Clin Immunol; 1991 Mar; 87(3):737-46. PubMed ID: 2005328
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Double-blind, placebo-controlled immunotherapy with mixed grass-pollen allergoids. IV. Comparison of the safety and efficacy of two dosages of a high-molecular-weight allergoid.
    Bousquet J; Hejjaoui A; Soussana M; Michel FB
    J Allergy Clin Immunol; 1990 Feb; 85(2):490-7. PubMed ID: 2406327
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of sublingual swallow immunotherapy in children with severe grass pollen allergic symptoms: a double-blind placebo-controlled study.
    Bufe A; Ziegler-Kirbach E; Stoeckmann E; Heidemann P; Gehlhar K; Holland-Letz T; Braun W
    Allergy; 2004 May; 59(5):498-504. PubMed ID: 15080830
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Double-blind, placebo-controlled immunotherapy with mixed grass-pollen allergoids. II. Comparison between parameters assessing the efficacy of immunotherapy.
    Bousquet J; Maasch H; Martinot B; Hejjaoui A; Wahl R; Michel FB
    J Allergy Clin Immunol; 1988 Sep; 82(3 Pt 1):439-46. PubMed ID: 3170992
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Double-blind, placebo-controlled immunotherapy with mixed grass-pollen allergoids. I. Rush immunotherapy with allergoids and standardized orchard grass-pollen extract.
    Bousquet J; Hejjaoui A; Skassa-Brociek W; Guérin B; Maasch HJ; Dhivert H; Michel FB
    J Allergy Clin Immunol; 1987 Oct; 80(4):591-8. PubMed ID: 3668124
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunologic effects and tolerability profile of in-season initiation of a standardized-quality grass allergy immunotherapy tablet: a phase III, multicenter, randomized, double-blind, placebo-controlled trial in adults with grass pollen-induced rhinoconjunctivitis.
    Reich K; Gessner C; Kroker A; Schwab JA; Pohl W; Villesen H; Wüstenberg E; Emminger W
    Clin Ther; 2011 Jul; 33(7):828-40. PubMed ID: 21741092
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Both sublingual and supralingual routes of administration are effective in long-term allergen-specific immunotherapy.
    Panzner P; Petráš M; Sýkora T; Lesná IK; Liška M
    Allergy Asthma Proc; 2011; 32(2):142-50. PubMed ID: 21439167
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunologic effect and tolerability of intra-seasonal subcutaneous immunotherapy with an 8-day up-dosing schedule to 10,000 standardized quality-units: a double-blind, randomized, placebo-controlled trial.
    Pfaar O; Wolf H; Klimek L; Schnitker J; Wüstenberg E
    Clin Ther; 2012 Oct; 34(10):2072-81. PubMed ID: 23063373
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Double-blind, placebo-controlled evaluation of grass pollen specific immunotherapy with oral drops administered sublingually or supralingually.
    Panzner P; Petrás M; Sýkora T; Lesná I
    Respir Med; 2008 Sep; 102(9):1296-304. PubMed ID: 18585908
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effects of grass pollen allergoid immunotherapy on clinical and immunological parameters in children with allergic rhinitis.
    Keskin O; Tuncer A; Adalioglu G; Sekerel BE; Saçkesen C; Kalayci O
    Pediatr Allergy Immunol; 2006 Sep; 17(6):396-407. PubMed ID: 16925684
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Short-term immunotherapy: a prospective, randomized, double-blind, placebo-controlled multicenter study of molecular standardized grass and rye allergens in patients with grass pollen-induced allergic rhinitis.
    Zenner HP; Baumgarten C; Rasp G; Fuchs T; Kunkel G; Hauswald B; Ring J; Effendy I; Behrendt W; Frosch PJ; Przybilla B; Brunner FX; Merk HF; Kapp A; Schnitker J; Wolf H
    J Allergy Clin Immunol; 1997 Jul; 100(1):23-9. PubMed ID: 9257783
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Local nasal immunotherapy with extract in powder form is effective and safe in grass pollen rhinitis: a double-blind study.
    Andri L; Senna G; Betteli C; Givanni S; Andri G; Dimitri G; Falagiani P; Mezzelani P
    J Allergy Clin Immunol; 1996 Jan; 97(1 Pt 1):34-41. PubMed ID: 8568135
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Specific IgE response before and after rush immunotherapy with a standardized allergen or allergoid in grass pollen allergy.
    Bousquet J; Braquemond P; Feinberg J; Guerin B; Maasch H; Michel FB
    Ann Allergy; 1986 Jun; 56(6):456-9. PubMed ID: 3717711
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Double-blind, placebo-controlled rush immunotherapy with a standardized Alternaria extract.
    Horst M; Hejjaoui A; Horst V; Michel FB; Bousquet J
    J Allergy Clin Immunol; 1990 Feb; 85(2):460-72. PubMed ID: 2406323
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical efficacy of microencapsulated timothy grass pollen extract in grass-allergic individuals.
    TePas EC; Hoyte EG; McIntire JJ; Umetsu DT
    Ann Allergy Asthma Immunol; 2004 Jan; 92(1):25-31. PubMed ID: 14756461
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sublingual immunotherapy with a standardised grass pollen extract; a double-blind placebo-controlled study.
    Hordijk GJ; Antvelink JB; Luwema RA
    Allergol Immunopathol (Madr); 1998; 26(5):234-40. PubMed ID: 9885731
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Depigmented-polymerized mixed grass/birch pollen extract immunotherapy is effective in polysensitized patients.
    Pfaar O; Biedermann T; Klimek L; Sager A; Robinson DS
    Allergy; 2013 Oct; 68(10):1306-13. PubMed ID: 23991896
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Short-term preseasonal immunotherapy: is early clinical efficacy related to the basophil response?
    Kepil Özdemir S; Sin BA; Güloğlu D; İkincioğulları A; Gençtürk Z; Mısırlıgil Z
    Int Arch Allergy Immunol; 2014; 164(3):237-45. PubMed ID: 25170594
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Grass pollen sublingual immunotherapy: a double-blind, placebo-controlled study in elderly patients with seasonal allergic rhinitis.
    Bozek A; Kolodziejczyk K; Warkocka-Szoltysek B; Jarzab J
    Am J Rhinol Allergy; 2014; 28(5):423-7. PubMed ID: 25198030
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.